Research Facility

Montreal, Quebec H3T 1E2

1 studies enrolling now · 8 studies all time

What they study most

Arrhythmias, Carcinoid, Carcinoid Tumor, Chronic Constipation, GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors, Pancreatic NET, Postmenopausal, Solid Tumor, Somatostatin Receptor

Studies at this site

• Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. — Recruiting now
• Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy — Recruiting now
• Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs) — Completed
• A Comparison of Once a Day Dose Compared to 2 Doses/Day — Completed
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis — Completed
• Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD — Completed
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis — Completed
• Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation — Stopped early